Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliza A Hawkes

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Blood|December 10, 2020
Can PET eradicate irradiation in PMBCL?Eliza A Hawkes
Hematology. American Society of Hematology. Education Program|December 7, 2024
Predicting bispecific antibody failure in diffuse large B-cell lymphomaAllison Barraclough, Eliza A Hawkes
Seminars in Hematology|December 10, 2023
Antibody and immunotherapy in diffuse large B-cell lymphomaAllison Barraclough, Eliza A Hawkes
British Journal of Haematology|April 6, 2024
Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be moreArina Martynchyk, Eliza A Hawkes
The Lancet. Oncology|July 4, 2014
ASPECCT: panitumumab versus cetuximab for colorectal cancerEliza A Hawkes, Rachel Wong
Nature Reviews. Clinical Oncology|August 28, 2010
Flexible sigmoidoscopy--valuable in colorectal cancerEliza A Hawkes, David Cunningham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2017
Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life SupportStephen Opat, Eliza A Hawkes
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2025
SOHO State of the Art Updates and Next Questions | Does Limited Stage Diffuse Large B-cell Lymphoma Matter?Arina Martynchyk, Eliza A Hawkes
Blood|December 28, 2023
Tribulations of trials in aggressive lymphomaAllison Barraclough, Eliza A Hawkes
Leukemia & Lymphoma|May 24, 2012
Diagnosis and management of rare gastrointestinal lymphomasEliza A Hawkes, Andrew Wotherspoon, David Cunningham
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Blood|December 10, 2020
Can PET eradicate irradiation in PMBCL?Eliza A Hawkes
Hematology. American Society of Hematology. Education Program|December 7, 2024
Predicting bispecific antibody failure in diffuse large B-cell lymphomaAllison Barraclough, Eliza A Hawkes
Seminars in Hematology|December 10, 2023
Antibody and immunotherapy in diffuse large B-cell lymphomaAllison Barraclough, Eliza A Hawkes
British Journal of Haematology|April 6, 2024
Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be moreArina Martynchyk, Eliza A Hawkes
The Lancet. Oncology|July 4, 2014
ASPECCT: panitumumab versus cetuximab for colorectal cancerEliza A Hawkes, Rachel Wong
Nature Reviews. Clinical Oncology|August 28, 2010
Flexible sigmoidoscopy--valuable in colorectal cancerEliza A Hawkes, David Cunningham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2017
Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life SupportStephen Opat, Eliza A Hawkes
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2025
SOHO State of the Art Updates and Next Questions | Does Limited Stage Diffuse Large B-cell Lymphoma Matter?Arina Martynchyk, Eliza A Hawkes
Blood|December 28, 2023
Tribulations of trials in aggressive lymphomaAllison Barraclough, Eliza A Hawkes
Leukemia & Lymphoma|May 24, 2012
Diagnosis and management of rare gastrointestinal lymphomasEliza A Hawkes, Andrew Wotherspoon, David Cunningham
Pageof 12